Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases

被引：0
|
作者：
Zhenhong Wang
Jian An
Chaohua Wang
机构：
[1] Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics,Department of Gynecology
[2] Fujian Medical University,Department of Gynecology, Women and Children’s Hospital, School of Medicine
[3] Xiamen University,Department of Gynecology and Obstetrics
[4] Peking University People’s Hospital,undefined
来源：
BMC Women's Health | / 22卷
关键词：
Chemotherapy; Premature ovarian failure; Perimenopausal symptoms; Myeloablative regimen; Leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Preventing ovarian hyperstimulation with gonadotropin-releasing hormone agonist trigger: is anything perfect?
    Filicori, Marco
    FERTILITY AND STERILITY, 2014, 101 (04) : 936 - 937
  • [22] Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin
    Vollaard, Esther S.
    van Beek, Andre P.
    Verburg, Frederik A. J.
    Roos, Annemieke
    Land, Jolande A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (05): : 1197 - 1201
  • [23] GONADOTROPIN-RELEASING HORMONE AGONIST INHIBITS PHYSIOLOGIC OVARIAN FOLLICULAR LOSS IN RATS
    ATAYA, K
    TADROS, M
    RAMAHI, A
    ACTA ENDOCRINOLOGICA, 1989, 121 (01): : 55 - 60
  • [24] OVARIAN-CYST FORMATION - A COMPLICATION OF GONADOTROPIN-RELEASING HORMONE AGONIST THERAPY
    FELDBERG, D
    ASHKENAZI, J
    DICKER, D
    YESHAYA, A
    GOLDMAN, GA
    GOLDMAN, JA
    FERTILITY AND STERILITY, 1989, 51 (01) : 42 - 45
  • [25] Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy
    Kim, Hee Jeong
    Lee, Moo Hyun
    Lee, Jeong Eon
    Park, Seho
    Lee, Eun Sook
    Kang, Yong Joon
    Shin, Hae Na
    Kim, Seung Il
    Lee, Jun Ho
    Im, Seock Ah
    Ahn, Sei Hyun
    Lee, Keun Seok
    Sohn, Joohyuk
    Kim, Seonok
    Nam, Seok Jin
    Han, Wonshik
    CLINICAL BREAST CANCER, 2018, 18 (05) : E1165 - E1172
  • [26] Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger
    Fatemi, Human Mousavi
    Garcia-Velasco, Juan
    FERTILITY AND STERILITY, 2015, 103 (04) : 870 - 873
  • [27] BINDING OF GONADOTROPIN-RELEASING HORMONE AGONIST TO RAT OVARIAN GRANULOSA-CELLS
    JONES, PBC
    CONN, PM
    MARIAN, J
    HSUEH, AJW
    LIFE SCIENCES, 1980, 27 (22) : 2125 - 2132
  • [28] OVARIAN RESPONSE TO HUMAN MENOPAUSAL GONADOTROPIN AFTER THERAPY WITH THE GONADOTROPIN-RELEASING HORMONE AGONIST LEUPROLIDE
    NADER, S
    BERKOWITZ, AS
    WINKEL, CA
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1988, 158 (02) : 403 - 404
  • [29] Fertility Preservation by Endocrine Suppression of Ovarian Function Using Gonadotropin-Releasing Hormone Agonists: The End of the Controversy?
    Blumenfeld, Zeev
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1895 - +
  • [30] OVARIAN FUNCTION PRESERVATION WITH GONADOTROPIN-RELEASING HORMONE ANALOGUES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH CYCLOPHOSPHAMIDE
    Pacucci, V. A.
    Ceccarelli, F.
    Perrone, G.
    Zannini, I.
    Candelieri, M.
    Leccese, I.
    Perricone, C.
    Miranda, F.
    Truglia, S.
    Spinelli, F. R.
    Alessandri, C.
    Valesini, G.
    Conti, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 872 - 872
12345